STATE STREET CORP - SIENNA BIOPHARMACEUTICALS IN ownership

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 43 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$547,000
+3.4%
235,967
+3.6%
0.00%
Q4 2018$529,000
-84.6%
227,818
-1.9%
0.00%
Q3 2018$3,441,000
+3.6%
232,226
+6.2%
0.00%
Q2 2018$3,322,000
-14.6%
218,598
+5.6%
0.00%
Q1 2018$3,888,000
+362.9%
207,026
+347.5%
0.00%
Q4 2017$840,000
+43.3%
46,259
+75.8%
0.00%
Q3 2017$586,00026,3070.00%
Other shareholders
SIENNA BIOPHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Golden State Wealth Management, LLC 180,552$36,0000.01%
MILLENNIUM MANAGEMENT LLC 122,942$24,0000.00%
CITIGROUP INC 1,739$00.00%
GOLDMAN SACHS GROUP INC 52,553$11,0000.00%
MORGAN STANLEY 101$00.00%
ACADIAN ASSET MANAGEMENT LLC 15,936$3,0000.00%
BANK OF MONTREAL /CAN/ 20$00.00%
BlackRock Inc. 90,036$18,0000.00%
Ballentine Partners, LLC 16,700$3,0000.00%
Citadel Advisors 83,839$17,0000.00%
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders